A Feasibility Study of en-bloc Systemic Lymph nodes Dissection with Pulmonary Lobectomy for patients with resectable non-small-cell lung cancer

A Feasibility Study of en-bloc Systemic Lymph nodes Dissection with Pulmonary Lobectomy for patients with resectable non-small-cell lung cancer - En-bloc Feasibility Study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035261

Enrollment

105

Registered

2018-12-15

Start date

2018-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Resectable non small cell lung cancer

Interventions

en-bloc Systemic Lymph nodes Dissection with Pulmonary Lobectomy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Resectable non small cell lung cancer Systemic Lymph nodes Dissection with Pulmonary Lobectomy PS 0-1

Exclusion criteria

Exclusion criteria: subjects with interstitial lung disease. Receiving continuous systemic corticosteroid. Patients poorly controlled diabetes. Dementia or psychological disorder difficult to participate in this clinical study.

Design outcomes

Primary

Measure	Time frame
Perioperative complications	—

Secondary

Measure	Time frame
Completion ratio of en-bloc Systemic Lymph nodes Dissection with Pulmonary Lobectomy. Operation time. Bleeding volume. Hospital stay. Drain indwelling time. Complication rate. Perioperative mortality rate. Complete resection ratio. overall survival. progression free survival.	—

Countries

Japan

Contacts

Public ContactToshiyuki Nagata

Kagoshima University Graduate School of Medical and Dental Sciences Department of General Thoracic Surgery

nagatosh@m2.kufm.kagoshima-u.ac.jp099-275-6490

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026